“Development of Modified Alicyclic Amines as Metabolically Stable Dopamine Transporter Inhibitors for Psychostimulant Use Disorders”

https://pubmed.ncbi.nlm.nih.gov/38117239

The development of modified 1-(4-(2-bis(4-fluorophenyl)methyl)sulfinyl)alkyl alicyclic amines as improved metabolically stable atypical dopamine transporter inhibitors for potential therapy in psychostimulant use disorders.